The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease
Open accessAbstract
BACKGROUND The everolimus-eluting bioresorbable vascular scaffold (BVS) is designed to achieve results comparable to metallic drug-eluting stents at 1 year, with improved long-term outcomes. Whether the 1-year clinical and angiographic results of BVS are noninferior to current-generation drug-eluting stents has not been established. OBJECTIVES This study sought to evaluate the angiographic efficacy and clinical safety and effectiveness of BVS in a randomized trial designed to enable approval of the BVS in China. METHODS Eligible patients with 1 or 2 de novo native coronary artery lesions were randomized to BVS or cobalt-chromium everolimus-eluting stents (CoCr-EES) in a 1:1 ratio stratified by diabetes and the number of lesions treated. Angiographic and clinical follow-up were planned at 1 year in all patients. The primary endpoint was angiographic in-segment late loss (LL), powered for noninferiority with a margin of 0.15 mm. RESULTS A total of 480 patients were randomized (241 BVS vs. 239 CoCr-EES) at 24 sites. Acute clinical device success (98.0% vs. 99.6%; p = 0.22) and procedural success (97.0% and 98.3%; p = 0.37) were comparable in BVS- and CoCr-EES-treated patients, respectively. The primary endpoint of in-segment LL at 1 year was 0.19 ± 0.38 mm for BVS versus 0.13 ± 0.38 mm for CoCr-EES; the 1-sided 97.5% upper confidence limit of the difference was 0.14 mm, achieving noninferiority of BVS compared with CoCr-EES (pnoninferiority = 0.01). BVS and CoCr-EES also had similar 1-year rates of target lesion failure (cardiac death, target vessel myocardial infarction, or ischemia-driven target lesion revascularization; 3.4% vs. 4.2%, respectively; p = 0.62) and definite/probable scaffold/stent thrombosis (0.4% vs. 0.0%, respectively; p = 1.00). CONCLUSIONS In the present multicenter randomized trial, BVS was noninferior to CoCr-EES for the primary endpoint of in-segment LL at 1 year. (A Clinical Evaluation of Absorb Bioresorbable Vascular Scaffold [Absorb BVS] System in Chinese Population-ABSORB CHINA Randomized Controlled Trial [RCT]; NCT01923740).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions
Cutlip, D. E., Windecker, S., Mehran, R., Boam, A., Cohen, D. J., van Es, G.-A., Gabriel Steg, P., Morel, M.-A., Mauri, L., Vranckx, P., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.685313 · Cited by 5,497
Synthetic biodegradable polymers as orthopedic devices
Middleton, J. C., & Tipton, A. J. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00101-0 · Cited by 2,741
Stone, G. W. (2008) · JAMA · doi:10.1001/jama.299.16.1903 · Cited by 582
Self-citationSerruys, P. W., Chevalier, B., Dudek, D., Cequier, A., Carrié, D., Iniguez, A., Dominici, M., van der Schaaf, R. J., Haude, M., Wasungu, L., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61455-0 · Cited by 564
Puricel, S., Arroyo, D., Corpataux, N., Baeriswyl, G., Lehmann, S., Kallinikou, Z., Muller, O., Allard, L., Stauffer, J.-C., Togni, M., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.12.017 · Cited by 203
Outline of the Report on Cardiovascular Disease in China, 2010
Hu-Sheng, Shou, Kong, Ling, Zhi, Gao, G., Run, Lin, Zhu, Man, et al. (2012) · 生物医学与环境科学:英文版 · Cited by 170
Angiographic Surrogate End Points in Drug-Eluting Stent Trials
Pocock, S. J., Lansky, A. J., Mehran, R., Popma, J. J., Fahy, M. P., Na, Y., Dangas, G., Moses, J. W., Pucelikova, T., Kandzari, D. E., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.07.084 · Cited by 162
Self-citationThe Clinical Impact of Routine Angiographic Follow-Up in Randomized Trials of Drug-Eluting Stents
Uchida, T., Popma, J. J., Stone, G. W., Ellis, S. G., Turco, M. A., Ormiston, J. A., Muramatsu, T., Nakamura, M., Nanto, S., Yokoi, H., et al. (2010) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2010.01.010 · Cited by 104
Self-citationCardiovascular diseases in China: Current status and future perspectives
Li, H., & Ge, J. (2014) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2014.10.002 · Cited by 101
Bioabsorbable Fixation Devices: Status for the Craniomaxillofacial Surgeon
Pietrzak, W. S., Verstynen, M. L., & Sarver, D. R. (1997) · Journal of Craniofacial Surgery · doi:10.1097/00001665-199703000-00005 · Cited by 76
Cited by
2018 ESC/EACTS guidelines on myocardial revascularization
Neumann, F.-J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy394 · Cited by 7,167
Levine, G. N., Bates, E. R., Bittl, J. A., Brindis, R. G., Fihn, S. D., Fleisher, L. A., Granger, C. B., Lange, R. A., Mack, M. J., Mauri, L., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.513 · Cited by 1,641
Levine, G. N., Bates, E. R., Bittl, J. A., Brindis, R. G., Fihn, S. D., Fleisher, L. A., Granger, C. B., Lange, R. A., Mack, M. J., Mauri, L., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000404 · Cited by 1,355
2018 ESC/EACTS Guidelines on myocardial revascularization
Neumann, F.-J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · EuroIntervention · doi:10.4244/eijy19m01_01 · Cited by 1,259
2018 ESC/EACTS Guidelines on myocardial revascularization
Sousa-Uva, M., Neumann, F.-J., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezy289 · Cited by 989
Metadata
- Authors
- Gao, R., Yang, Y., Han, Y., Huo, Y., Chen, J., Yu, B., Su, X., Li, L., Kuo, H.-C., Ying, S.-W., Cheong, W.-F., Zhang, Y., Su, X., Xu, B., Popma, J. J., & Stone, G. W.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 66
- Issue
- 21
- Pages
- 2298-2309
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2107339273
- Cited by
- 252
- References
- 11
- FWCI
- 52.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease. https://app.cochat.ai/papers/10.1016/j.jacc.2015.09.054
- The paper
- Gao, R., Yang, Y., Han, Y., Huo, Y., Chen, J., Yu, B., Su, X., Li, L., Kuo, H.-C., Ying, S.-W., Cheong, W.-F., Zhang, Y., Su, X., Xu, B., Popma, J. J., & Stone, G. W. (2015). Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2015.09.054
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.